Linking preclinical data to clinical reality

Immueed specializes in advanced ex vivo characterization of biotherapeutics to provide better understanding of first-in-man reactions prior to clinical trial entry.

What we do

Immuno-Service

We offer a specialized service based on a unique human whole-blood loop assay, for detection of acute immune-related side effects of biopharmaceuticals (cytokine release), which provides a better understanding of first-in-man reactions prior to clinical trial entry. The assay platform can also be used to perform mode-of-action studies.

Immuno-Oncology

We are developing a new generation therapeutic peptide-based immuno-oncology vaccine powered by proprietary and patent-protected advanced TET technology that will enhance both peptide uptake and cellular immune activation. Our strategy is based on the delivery of our vaccine in an antigen-antibody immune complex formula.

Sign up!

Meet us at Nordic Life Science Days in Stockholm Waterfront, September 10-12. During the conference Justyna Leja-Jarblad, COO will be available for partnering meetings. If you are interested in our Immuno-Service, potential collaboration or insights regarding preclinical drug development, contact us through partneringONE.

We are proud to announce that Immuneed is one of the winners of the Bona Postulata prize 2018, alongside our collaborators, Clinical Trial Consultants (CTC).

Quick Links

Dag Hammarskjölds väg 13a | 752 37 Uppsala, Sweden | info@immuneed.com